Frost & Sullivan

Syndicate content

Drug patents expiry to give generic pharma market shot in arm

drugs2_0.jpg.crop_display.jpg

The patent expiry of several major 'blockbuster' drugs, coupled with other factors, will fuel growth of global generic pharmaceuticals market by 2017, research firm Frost & Sullivan said.

"Immi

No Articles Found

No Articles Found

No Articles Found

I want to begin with a little story that was told to me by a leading executive at Aptech. He was exercising in a gym with a lot of younger people.

Shekhar Kapur’s Bandit Queen didn’t make the cut. Neither did Shaji Karun’s Piravi, which bagged 31 international awards.